Raydn Back to the front page ◐ StockINCYIncyte122.30-2.02%livePrice as of Tuesday, September 29, 2026 at 12:25 PM ETRaydn storiesSep 28, 8:10 AM ETMirum and Incyte win FDA approval for Atebrioz in rare bone disease